The global orthopedic biomaterials market size is expected to reach USD 23.5 billion by 2025 registering a CAGR of 10.3%, according to a new report by Grand View Research, Inc. Increasing incidence of degenerative joint disease and musculoskeletal disorders is the key factor driving the market. In addition, increasing geriatric population susceptible to orthopedic conditions arising due to low bone density and advancing bone related disorders is expected to boost the product demand over the forecast period.
Ceramics & bioactive glass was the dominant material type segment in 2018 on account of growing demand for these materials due to their high compression strength. In addition, ceramics & bioactive glass biomaterials are preferred over their counterparts as they have a high affinity to integrate with the surface material of the bone. However, polymer biomaterial segment is expected to witness the fastest CAGR from 2019 to 2025 owing to high usage of these materials for the reconstruction and fixation procedures of the spine, hip, and knee.
Request a sample Copy of the Global Orthopedic Biomaterials Market Research Report @ www.grandviewresearch.com/industry-analysis/orthopedic-biomaterials-market/request/rs1
Orthopedic implants led the application segment in 2018 and are expected to remain dominant over the forecast period. Increasing number of trauma cases is one of the major factors driving the growth of this segment. Orthobiologics segment is anticipated to witness the fastest CAGR of 10.8% from 2019 to 2025. Increasing adoption of biomaterials in various orthobiologics for the treatment of spinal and other reconstructive surgeries is anticipated to drive the growth of this segment.
Led by U.S. North America led the market in 2018 owing to high demand for joint replacement/reconstruction, bone repair, and, other orthopedic procedures due to the presence of target population. Moreover, rise in the demand for advanced treatment options coupled with increasing awareness about bio-resorbable products is expected to drive the product demand in future.
Further key findings from the report suggest:
- North America accounted for the largest revenue share in 2018 owing to large patient pool and high awareness regarding the use of bio-resorbable biomaterials
- Ceramics and bioactive glass segment led the market in 2018 owing to increased usage of these biomaterials for the restoration of damaged tissue and fixation surgeries and joint replacement surgeries
- Orthopedic implants was the dominant application segment in 2018 due to an increased number of trauma cases worldwide
- Some of the key companies in orthopedic biomaterials market are DSM Biomedical; Evonik Industries AG; Stryker Corp.; DePuy Synthes, Inc.; Zimmer Biomet; Invibio Ltd.; Globus Medical; Exactech, Inc.; Matexcel; AdvanSource Biomaterials Corp.; CAM Bioceramics B.V.; and Heraeus Holding
Have Any Query? Ask Our Experts @ www.grandviewresearch.com/inquiry/1085/ibb
Grand View Research has segmented the global orthopedic biomaterials market on the basis of material type, application, and region:
Orthopedic Biomaterials Material Type Outlook (Revenue, USD Million, 2014 – 2025)
- Ceramics & Bioactive Glasses
- Calcium Phosphate Cements
Orthopedic Biomaterials Application Outlook (Revenue, USD Million, 2014 – 2025)
- Orthopedic Implants
- Joint Replacement/Reconstruction
- Bio-resorbable Tissue Fixation
Orthopedic Biomaterials Regional Outlook (Revenue, USD Million, 2014 – 2025)
- North America
- Asia Pacific
- South Korea
- Latin America
- South Africa
- Saudi Arabia
Browse Related Category @
Intraoperative Imaging Market – www.grandviewresearch.com/industry-analysis/intraoperative-imaging-market
Hip Replacement Implants Market – www.grandviewresearch.com/industry-analysis/hip-replacement-implants-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research Guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
Country: United States